The partnership will combine Syclo’s Agentry tool, a development system designed to extend enterprise systems onto mobile devices and deliver software that works offline or in real-time, with Stelex’s knowledge of the life sciences industry and regulatory issues.
The aim of the partnership is to enable businesses to deploy mobile technologies that meet the FDA’s electronic record-keeping requirements.
The alliance will help aid life sciences organizations comply with new regulations such as Sarbanes-Oxley.
In this age of mobility, life sciences companies are looking for cost- effective solutions to provide timely information to decision-makers while meeting the ever-changing regulatory requirements, said Daniel Matlis, vice president at Stelex. The combination of Syclo’s Agentry platform and Stelex’ implementation and compliance services provides clients with a complete solution to provide just-in-time information in the mobile age.
